Tokyo Women's Medical University, in collaboration with Port Inc., will conduct an empirical study of the effects of "urban remote medical care" utilizing the IoT (Internet of Things) to improve the convenience of medical examinations in urban areas. ..
Patients with lifestyle-related diseases who have to go to the hospital for a long period of time and continue to receive treatment.Even in highly convenient urban areas, the use of crowded public transportation and the time burden are heavy.Telemedicine, which uses information and communication technology and does not require face-to-face medical examinations with doctors, is expected to eliminate such annoyance.However, telemedicine in Japan is not yet common, and the current situation is that no large-scale study has been made on its safety and efficacy.
This time, a clinical trial jointly conducted by Tokyo Women's Medical University with Port Inc. can prove that hypertension treatment by non-face-to-face telemedicine using IoT is not inferior to or superior to conventional medical treatment. Purpose.Specifically, we will examine whether non-face-to-face telemedicine is as safe as conventional medical care, whether better blood pressure control can be obtained, and whether it is also economically efficient.
The subjects of clinical trials are patients with essential hypertension who are 20 years of age or older.In the flow of remote medical care, first, the patient performs self-blood pressure measurement at least 9200 times a week using the OMRON automatic blood pressure monitor HEM-3T *, and sends the measurement data to the server at any time via his / her own smartphone or the like.The attending physician regularly refers to home blood pressure data to determine the treatment policy.After that, the doctor in charge informs the patient of the findings and treatment policy using communication means such as chat and e-mail as needed in addition to telephone, and prescribes the internal medicine after confirming the intention with the patient.The prescribed oral medication is mailed to the patient's home.
If it can be proved that the patient's blood pressure can be judged more accurately and controlled safely and well in the clinical trial of remote medical care using the network sphygmomanometer, it will be possible to prevent cardiovascular disease, as well as to go to the hospital or see a doctor. It is expected that waiting time will not be required, which will lead to improvement of the efficiency of patients' work and life, and saving of medical expenses.
* The OMRON automatic blood pressure monitor HEM-9200T can transfer and manage measurement data to the Port Medical blood pressure management app.
